TGFB1 and colitis: In colitis, elevated TGF-β expression dampens inflammation, and one therapeutic avenue has been to boost TGF-β efficacy by anti-sense RNA abrogation of the Smad7 inhibitor of the TGF-β signaling pathway (Monteleone et al., 2015).